- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 23.04. | Ipsen and Skyhawk partner to develop rare neurological therapies | ||
| 23.04. | EC approves Pfizer's Emblaveo for multidrug-resistant infections | ||
| 22.04. | Hyundai to advance cancer study plans for niclosamide-based drug | ||
| 22.04. | Tymlos outperforms teriparatide in real-world fracture analysis | ||
| 22.04. | Chiesi champions new inhaler propellant to reduce carbon footprint | ||
| 22.04. | Takeda and others sign agreement to form early drug discovery incubation JV | ||
| 22.04. | Health Canada approves Nora Pharma for commercialisation of NIOPEG | ||
| 22.04. | BioArctic partners with Eisai on Alzheimer's treatment | ||
| 22.04. | Health Canada approves Merck's Keytruda for gastric cancer treatment | ||
| 19.04. | SGN-1 by Guangzhou Huajin Pharmaceutical Technology for Sarcomas: Likelihood of Approval | ||
| 19.04. | SGN-1 by Guangzhou Huajin Pharmaceutical Technology for Non-Small Cell Lung Cancer: Likelihood of Approval | ||
| 19.04. | SGN-1 by Guangzhou Huajin Pharmaceutical Technology for Breast Cancer: Likelihood of Approval | ||
| 19.04. | JS-006 by Shanghai Junshi Biosciences for Non-Small Cell Lung Cancer: Likelihood of Approval | ||
| 19.04. | JS-006 by Shanghai Junshi Biosciences for Hepatocellular Carcinoma: Likelihood of Approval | ||
| 19.04. | JS-006 by Shanghai Junshi Biosciences for Solid Tumor: Likelihood of Approval | ||
| 19.04. | Alvotech moves to bring its Humira biosimilar to US market | ||
| 19.04. | Rigosertib sodium by Traws Pharma for Metastatic Melanoma: Likelihood of Approval | ||
| 19.04. | Vertex's pain drug suzetrigine advances in FDA approval process | ||
| 19.04. | Roche wins second FDA label expansion for Alecensa in NSCLC | ||
| 19.04. | Inhibikase sees "opportunity" in cardiopulmonary disease for IkT-001Pro | ||
| 19.04. | Q&A: Cell and gene therapy value assessments need a rework to allow access | ||
| 19.04. | AskBio's AB-1002 gene therapy receives FDA fast-track status | ||
| 19.04. | API biologics (protein and peptide) companies in contract manufacturing | ||
| 19.04. | Evotec and Variant Bio forge antifibrotic drug discovery partnership | ||
| 19.04. | Clinical trial packaging services in contract manufacturing for the pharmaceutical industry |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
